UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000031125 |
|---|---|
| Receipt number | R000035554 |
| Scientific Title | Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood |
| Date of disclosure of the study information | 2018/02/21 |
| Last modified on | 2020/01/28 13:03:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood
Acronym
Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood
Scientific Title
Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood
Scientific Title:Acronym
Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood
Region
| Japan |
Condition
Condition
cardiac surgery cases
Classification by specialty
| Anesthesiology | Cardiovascular surgery | Blood transfusion |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
heparin concentration in cell saver blood
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
heparin concentration in cell saver blood
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 90 | years-old | > |
Gender
Male and Female
Key inclusion criteria
all cases of cardiac surgery with cell saver
Key exclusion criteria
none
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Tamura |
| Middle name | |
| Last name | Takahiro |
Organization
Nagoya University Graduate School of Medicine
Division name
Department of Anesthesiology
Zip code
466-8550
Address
Nagoya
TEL
052-741-2111
takahiro@med.nagoya-u.ac.jp
Public contact
Name of contact person
| 1st name | Tamura |
| Middle name | |
| Last name | Takahiro |
Organization
Nagoya University Graduate School of Medicine
Division name
Department of Anesthesiology
Zip code
466-8550
Address
Nagoya
TEL
052-741-2111
Homepage URL
takahiro@med.nagoya-u.ac.jp
Sponsor or person
Institute
Nagoya University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Nagoya University Graduate School of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
IRB, Nagoya University hospital
Address
Nagoya
Tel
+81527412111
takahiro@med.nagoya-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 02 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 02 | Month | 03 | Day |
Date of IRB
| 2019 | Year | 06 | Month | 04 | Day |
Anticipated trial start date
| 2018 | Year | 06 | Month | 04 | Day |
Last follow-up date
| 2019 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is to check again about concentration of heparin in cell saver blood. And we will check coagulation test of blood as INR, APTT, Fibrinogen as well.
Management information
Registered date
| 2018 | Year | 02 | Month | 03 | Day |
Last modified on
| 2020 | Year | 01 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035554
